Skip to content

Clinical trials

Completed Observational Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Observational Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20061
20072
20082
20092
20121
20141
20161
20191
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
Case Comprehensive Cancer Center2
University of Nebraska2
Aarhus University Hospital1
Alliance for Clinical Trials in Oncology1
City of Hope Medical Center1
Duke University1
Erasmus Medical Center1
European Organisation for Research and Treatment of Cancer - EORTC1
Institut Bergonié1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ21
Breast Neoplasms19
Carcinoma, Intraductal, Noninfiltrating7
Breast Neoplasms, Male3
Carcinoma, Lobular3
Carcinoma, Ductal, Breast2
Lymphedema2
Anxiety Disorders1
Blast Crisis1
Brain Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.